Inhibitor mediated Bcr-Abl degradation: A novel therapeutic approach for Chronic Myeloid Leukemia
Arifa Sayyidah Ahsan1, Marcus J. C. Long2, and Lizbeth Hedstrom3
1Undergraduate Program in Biochemistry, Brandeis University 2Graduate Program in Biochemistry, Brandeis University 3Departments of Biology and Chemistry, Brandeis University
Tunable Staged Release of Therapeutics from Layer-By-Layer Coating with Clay Interlayer Barrier
Jouha Min1,2, Richard D. Braatz1, and Paula T. Hammond1,2
1Department of Chemical Engineering, Massachusetts Institute of Technology 2David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology